<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02102776</url>
  </required_header>
  <id_info>
    <org_study_id>2014015</org_study_id>
    <nct_id>NCT02102776</nct_id>
  </id_info>
  <brief_title>Intraoperative Mitomycin C, Amniotic Membrane Transplantation and Conjunctival Autograft for Primary Pterygium</brief_title>
  <official_title>Intraoperative Mitomycin C Application, Amniotic Membrane Transplantation and Conjunctival Autograft After Primary Pterygium Excision: A Multi-center Randomized Clinical Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sun Yat-sen University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Sun Yat-sen University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this randomized multi-center clinical trial is to compare the efficacy and
      safety of intraoperative mitomycin C(MMC),amniotic membrane transplantation(AMT) and
      Conjunctival Autograft(CAG) for primary pterygium surgery. The investigators will also
      evaluate particular risk factors related to pterygium recurrence.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients with primary pterygium will be randomly assigned to undertake pterygium excision
      followed by intraoperative mitomycin C application,amniotic membrane transplantation or
      conjunctival autograft in five clinical centers. Multi-center collaboration and quality
      monitoring will be based on a website designed for this study. The patients will be followed
      at least 12 months. Corneal Recurrence as the primary outcome measure, is considered as a
      fibrovascular ingrowth beyond the limbus with conjunctival drag.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>December 2015</start_date>
  <completion_date type="Anticipated">December 2017</completion_date>
  <primary_completion_date type="Anticipated">December 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Recurrence of pterygium</measure>
    <time_frame>One year</time_frame>
    <description>Corneal Recurrence is considered as a fibrovascular ingrowth beyond the limbus with conjunctival drag</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Visual acuity</measure>
    <time_frame>One year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Healing time of corneal epithelium</measure>
    <time_frame>Four weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Healing time of conjunctival epithelium</measure>
    <time_frame>Four weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative complications</measure>
    <time_frame>One year</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">750</enrollment>
  <condition>Pterygium</condition>
  <arm_group>
    <arm_group_label>MMC after pterygium excision</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Intraoperative mitomycin C (0.02%) will be applied for 5 minutes after pterygium excision. The conjunctival defect will be left bare without graft.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>AMT after Pterygium Excision</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Amniotic membrane transplantation will be applied to cover the conjunctival defect after pterygium excision. No mitomycin C will be applied.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>CAG after Pterygium Excision</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>A conjunctival autograft will be harvested from the superior side of the operating eye's bulbar conjunctiva. Then the graft will be sutured to cover the conjunctival defect after pterygium excision. No mitomycin C will be applied.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>MMC</intervention_name>
    <description>Standardized cotton soaked in mitomycin C (0.02%) will be applied underneath conjunctiva for 5 minutes after pterygium excision.</description>
    <arm_group_label>MMC after pterygium excision</arm_group_label>
    <other_name>Intraoperative mitomycin C</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>AMT</intervention_name>
    <description>Amniotic membrane transplantation will be applied to cover the conjunctival defect after pterygium excision.</description>
    <arm_group_label>AMT after Pterygium Excision</arm_group_label>
    <other_name>Amniotic membrane transplantation</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>CAG</intervention_name>
    <description>A conjunctival autograft, harvested from the superior bulbar conjunctiva of the operating eye, will be applied to cover the conjunctival defect after pterygium excision.</description>
    <arm_group_label>CAG after Pterygium Excision</arm_group_label>
    <other_name>Conjunctival autograft</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Pterygium excision</intervention_name>
    <description>Pterygium head, minimal conjunctiva and anterior tenon's capsule underneath will be removed in the excision of pterygium tissue.</description>
    <arm_group_label>MMC after pterygium excision</arm_group_label>
    <arm_group_label>AMT after Pterygium Excision</arm_group_label>
    <arm_group_label>CAG after Pterygium Excision</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Primary pterygium

          -  Willingness to participate in research project and to attend research follow-up

          -  Adults (age 18 to 80 years old)

          -  Patients must not meet any of the following exclusion criteria

        Exclusion Criteria:

          -  Pregnant,breast-feeding women or patients with poor general health

          -  Patients with significant ocular or lid pathology, such as Sjogren's Syndrome,
             infection, exposure keratitis, glaucoma, active uveitis, retinal detachment and trauma

          -  Patients with previous surgery on ocular surface, such as trabeculectomy, strabismus
             surgery

          -  Patients with allergy to intraoperative or postoperative drugs, such as mitomycin C,
             tobramycin or local anesthetics
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Shiyou Zhou, M.D., Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Zhongshan Ophthalmic Center, Sun Yat-sen University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Shiyou Zhou, M.D., Ph.D.</last_name>
    <phone>86-02087331540</phone>
    <email>zhoushiy@mail.sysu.edu.cn</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Tao Zhou, M.D.</last_name>
    <phone>86-18126813938</phone>
    <email>taochou_tony@foxmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Zhongshan Ophthalmic Center, Sun Yat-sen University</name>
      <address>
        <city>Guangzhou</city>
        <state>Guangdong</state>
        <zip>510060</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Shiyou Zhou, M.D., Ph.D.</last_name>
      <phone>86-02087331540</phone>
      <email>zhoushiy@mail.sysu.edu.cn</email>
    </contact>
    <investigator>
      <last_name>Shiyou Zhou, M.D., Ph.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Tao Zhou, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Henan Provincial People's Hospital</name>
      <address>
        <city>Zhengzhou</city>
        <state>Henan</state>
        <zip>450003</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lei Zhu, M.D, Ph.D.</last_name>
      <email>Hnyks135@126.com</email>
    </contact>
    <contact_backup>
      <last_name>zhanrong Li, M.D, Ph.D.</last_name>
      <phone>86-18838270992</phone>
      <email>71203885@qq.com</email>
    </contact_backup>
    <investigator>
      <last_name>Lei Zhu, M.D, Ph.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Zhanrong Li, M.D, Ph.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Xi'an Eye Hospital</name>
      <address>
        <city>Xi'an</city>
        <state>Shanxi</state>
        <zip>710000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Haifeng Zhu, M.D., Ph.D.</last_name>
      <phone>86-13709118376</phone>
      <email>ZHF200309@163.com</email>
    </contact>
    <investigator>
      <last_name>Haifeng Zhu, M.D., Ph.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Sichuan Ganzi Autonomous Prefecture People's Hospital</name>
      <address>
        <city>Ganzi</city>
        <state>Sichuan</state>
        <zip>626000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jing Yang, M.D.</last_name>
      <phone>86-13568690606</phone>
      <email>1078812810@qq.com</email>
    </contact>
    <investigator>
      <last_name>Jing Yang, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Fourth Affiliated Hospital, Kunming Medical University</name>
      <address>
        <city>Kunming</city>
        <state>Yunnan</state>
        <zip>650000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Zhulin Hu, M.D., Ph.D.</last_name>
      <email>HZL77@263.net</email>
    </contact>
    <contact_backup>
      <last_name>Hai Liu, M.D.</last_name>
      <phone>86-13648845146</phone>
      <email>2560940908@qq.com</email>
    </contact_backup>
    <investigator>
      <last_name>Zhulin Hu, M.D., Ph.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Hai Liu, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>December 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 31, 2014</study_first_submitted>
  <study_first_submitted_qc>March 31, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 3, 2014</study_first_posted>
  <last_update_submitted>December 16, 2015</last_update_submitted>
  <last_update_submitted_qc>December 16, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 17, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Sun Yat-sen University</investigator_affiliation>
    <investigator_full_name>Shiyou Zhou</investigator_full_name>
    <investigator_title>M.D., Ph.D</investigator_title>
  </responsible_party>
  <keyword>Primary Pterygium</keyword>
  <keyword>Mitomycin C</keyword>
  <keyword>Amniotic membrane transplantation</keyword>
  <keyword>Conjunctival autograft</keyword>
  <keyword>Multi-center randomized clinical trial</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pterygium</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Mitomycins</mesh_term>
    <mesh_term>Mitomycin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

